Treatment of Cytomegalovirus Retinitis with Intravitreous Cidofovir in Patients with AIDS: A Preliminary Report

Firas M. Rahhal, J Fernando Arevalo, Eugenio Chavez De La Paz, David Munguia, Stanley P. Azen, William R. Freeman

Research output: Contribution to journalArticle

Abstract

Background: Cytomegalovirus retinitis remains a major cause of illness in patients with the acquired immunodeficiency syndrome (AIDS), and existing therapies for this condition are relatively ineffective and toxic. Objective: To evaluate the efficacy of intravitreous cidofovir injections alone for initial and maintenance therapy for cytomegalovirus retinitis. Design: Prospective, nonrandomized, consecutive case series. Setting: University ophthalmology referral clinic. Patients: 22 patients with AIDS and cytomegalovirus retinitis. In 15 of 32 affected eyes, intravitreous cidofovir was administered as the initial treatment for cytomegalovirus retinitis (group A); 17 eyes had previously been treated with intravenous therapy (group B). Intervention: All eyes were intravitreously injected with 20 μg of cidofovir at 5- to 6-week intervals. No patient in either group received systemic anticytomegalovirus therapy at any time during the study period. Measurements: Healing of retinitis was defined as resolution of retinal opacification and cessation of border progression. Progression, the primary end point, was defined as 750 microns of border progression or development of a new lesion. Results: The mean duration of follow-up was 15.3 weeks (range, 5 to 44 weeks). Of the eyes with active retinitis, 100% (95% Cl, 87% to 100%) healed in response to the initial injection. In two eyes (6%; Cl, 0% to 15%), two episodes of retinitis progression occurred (one in each eye). Both of these eyes were in a patient with clinically resistant retinitis. In 3% of eyes (Cl, 0% to 9%), the retina became detached. Mild iritis developed after 14% of the injections that had been preceded by prophylaxis with oral probenecid. Irreversible, visually significant hypotonia developed in one eye. Conclusion: Treatment and subsequent maintenance of cytomegalovirus retinitis with 20 μg of intravitreously injected cidofovir, given at 5- to 6-week intervals, is safe and highly effective.

Original languageEnglish (US)
Pages (from-to)98-103
Number of pages6
JournalAnnals of Internal Medicine
Volume125
Issue number2
StatePublished - Jul 15 1996

Fingerprint

Cytomegalovirus Retinitis
Acquired Immunodeficiency Syndrome
Retinitis
Therapeutics
Injections
Iritis
cidofovir
Probenecid
Muscle Hypotonia
Poisons
Ophthalmology
Group Psychotherapy
Retina
Referral and Consultation
Maintenance

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rahhal, F. M., Arevalo, J. F., De La Paz, E. C., Munguia, D., Azen, S. P., & Freeman, W. R. (1996). Treatment of Cytomegalovirus Retinitis with Intravitreous Cidofovir in Patients with AIDS: A Preliminary Report. Annals of Internal Medicine, 125(2), 98-103.

Treatment of Cytomegalovirus Retinitis with Intravitreous Cidofovir in Patients with AIDS : A Preliminary Report. / Rahhal, Firas M.; Arevalo, J Fernando; De La Paz, Eugenio Chavez; Munguia, David; Azen, Stanley P.; Freeman, William R.

In: Annals of Internal Medicine, Vol. 125, No. 2, 15.07.1996, p. 98-103.

Research output: Contribution to journalArticle

Rahhal, FM, Arevalo, JF, De La Paz, EC, Munguia, D, Azen, SP & Freeman, WR 1996, 'Treatment of Cytomegalovirus Retinitis with Intravitreous Cidofovir in Patients with AIDS: A Preliminary Report', Annals of Internal Medicine, vol. 125, no. 2, pp. 98-103.
Rahhal, Firas M. ; Arevalo, J Fernando ; De La Paz, Eugenio Chavez ; Munguia, David ; Azen, Stanley P. ; Freeman, William R. / Treatment of Cytomegalovirus Retinitis with Intravitreous Cidofovir in Patients with AIDS : A Preliminary Report. In: Annals of Internal Medicine. 1996 ; Vol. 125, No. 2. pp. 98-103.
@article{fe29bafa7ffe4a09b97d4c1ac01a257c,
title = "Treatment of Cytomegalovirus Retinitis with Intravitreous Cidofovir in Patients with AIDS: A Preliminary Report",
abstract = "Background: Cytomegalovirus retinitis remains a major cause of illness in patients with the acquired immunodeficiency syndrome (AIDS), and existing therapies for this condition are relatively ineffective and toxic. Objective: To evaluate the efficacy of intravitreous cidofovir injections alone for initial and maintenance therapy for cytomegalovirus retinitis. Design: Prospective, nonrandomized, consecutive case series. Setting: University ophthalmology referral clinic. Patients: 22 patients with AIDS and cytomegalovirus retinitis. In 15 of 32 affected eyes, intravitreous cidofovir was administered as the initial treatment for cytomegalovirus retinitis (group A); 17 eyes had previously been treated with intravenous therapy (group B). Intervention: All eyes were intravitreously injected with 20 μg of cidofovir at 5- to 6-week intervals. No patient in either group received systemic anticytomegalovirus therapy at any time during the study period. Measurements: Healing of retinitis was defined as resolution of retinal opacification and cessation of border progression. Progression, the primary end point, was defined as 750 microns of border progression or development of a new lesion. Results: The mean duration of follow-up was 15.3 weeks (range, 5 to 44 weeks). Of the eyes with active retinitis, 100{\%} (95{\%} Cl, 87{\%} to 100{\%}) healed in response to the initial injection. In two eyes (6{\%}; Cl, 0{\%} to 15{\%}), two episodes of retinitis progression occurred (one in each eye). Both of these eyes were in a patient with clinically resistant retinitis. In 3{\%} of eyes (Cl, 0{\%} to 9{\%}), the retina became detached. Mild iritis developed after 14{\%} of the injections that had been preceded by prophylaxis with oral probenecid. Irreversible, visually significant hypotonia developed in one eye. Conclusion: Treatment and subsequent maintenance of cytomegalovirus retinitis with 20 μg of intravitreously injected cidofovir, given at 5- to 6-week intervals, is safe and highly effective.",
author = "Rahhal, {Firas M.} and Arevalo, {J Fernando} and {De La Paz}, {Eugenio Chavez} and David Munguia and Azen, {Stanley P.} and Freeman, {William R.}",
year = "1996",
month = "7",
day = "15",
language = "English (US)",
volume = "125",
pages = "98--103",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "2",

}

TY - JOUR

T1 - Treatment of Cytomegalovirus Retinitis with Intravitreous Cidofovir in Patients with AIDS

T2 - A Preliminary Report

AU - Rahhal, Firas M.

AU - Arevalo, J Fernando

AU - De La Paz, Eugenio Chavez

AU - Munguia, David

AU - Azen, Stanley P.

AU - Freeman, William R.

PY - 1996/7/15

Y1 - 1996/7/15

N2 - Background: Cytomegalovirus retinitis remains a major cause of illness in patients with the acquired immunodeficiency syndrome (AIDS), and existing therapies for this condition are relatively ineffective and toxic. Objective: To evaluate the efficacy of intravitreous cidofovir injections alone for initial and maintenance therapy for cytomegalovirus retinitis. Design: Prospective, nonrandomized, consecutive case series. Setting: University ophthalmology referral clinic. Patients: 22 patients with AIDS and cytomegalovirus retinitis. In 15 of 32 affected eyes, intravitreous cidofovir was administered as the initial treatment for cytomegalovirus retinitis (group A); 17 eyes had previously been treated with intravenous therapy (group B). Intervention: All eyes were intravitreously injected with 20 μg of cidofovir at 5- to 6-week intervals. No patient in either group received systemic anticytomegalovirus therapy at any time during the study period. Measurements: Healing of retinitis was defined as resolution of retinal opacification and cessation of border progression. Progression, the primary end point, was defined as 750 microns of border progression or development of a new lesion. Results: The mean duration of follow-up was 15.3 weeks (range, 5 to 44 weeks). Of the eyes with active retinitis, 100% (95% Cl, 87% to 100%) healed in response to the initial injection. In two eyes (6%; Cl, 0% to 15%), two episodes of retinitis progression occurred (one in each eye). Both of these eyes were in a patient with clinically resistant retinitis. In 3% of eyes (Cl, 0% to 9%), the retina became detached. Mild iritis developed after 14% of the injections that had been preceded by prophylaxis with oral probenecid. Irreversible, visually significant hypotonia developed in one eye. Conclusion: Treatment and subsequent maintenance of cytomegalovirus retinitis with 20 μg of intravitreously injected cidofovir, given at 5- to 6-week intervals, is safe and highly effective.

AB - Background: Cytomegalovirus retinitis remains a major cause of illness in patients with the acquired immunodeficiency syndrome (AIDS), and existing therapies for this condition are relatively ineffective and toxic. Objective: To evaluate the efficacy of intravitreous cidofovir injections alone for initial and maintenance therapy for cytomegalovirus retinitis. Design: Prospective, nonrandomized, consecutive case series. Setting: University ophthalmology referral clinic. Patients: 22 patients with AIDS and cytomegalovirus retinitis. In 15 of 32 affected eyes, intravitreous cidofovir was administered as the initial treatment for cytomegalovirus retinitis (group A); 17 eyes had previously been treated with intravenous therapy (group B). Intervention: All eyes were intravitreously injected with 20 μg of cidofovir at 5- to 6-week intervals. No patient in either group received systemic anticytomegalovirus therapy at any time during the study period. Measurements: Healing of retinitis was defined as resolution of retinal opacification and cessation of border progression. Progression, the primary end point, was defined as 750 microns of border progression or development of a new lesion. Results: The mean duration of follow-up was 15.3 weeks (range, 5 to 44 weeks). Of the eyes with active retinitis, 100% (95% Cl, 87% to 100%) healed in response to the initial injection. In two eyes (6%; Cl, 0% to 15%), two episodes of retinitis progression occurred (one in each eye). Both of these eyes were in a patient with clinically resistant retinitis. In 3% of eyes (Cl, 0% to 9%), the retina became detached. Mild iritis developed after 14% of the injections that had been preceded by prophylaxis with oral probenecid. Irreversible, visually significant hypotonia developed in one eye. Conclusion: Treatment and subsequent maintenance of cytomegalovirus retinitis with 20 μg of intravitreously injected cidofovir, given at 5- to 6-week intervals, is safe and highly effective.

UR - http://www.scopus.com/inward/record.url?scp=0030585901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030585901&partnerID=8YFLogxK

M3 - Article

C2 - 8678386

AN - SCOPUS:0030585901

VL - 125

SP - 98

EP - 103

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 2

ER -